Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.29 USD | +2.24% | +20.65% | +0.17% |
02/05 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
02/05 | Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.17% | 12.15B | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
-1.24% | 11.99B | |
+19.33% | 11.64B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Bio-Techne, Thermo Fisher Scientific in Agreement to Develop, Commercialize Kidney Transplant Rejection Test ExoTRU